Insider Trading March 2, 2026

LifeVantage Director Dayton Judd Acquires $152,422 in Stock in Three Trades

Insider purchases total 33,197 shares as company reports mixed fiscal Q2 results and receives a lowered price target

By Caleb Monroe LFVN
LifeVantage Director Dayton Judd Acquires $152,422 in Stock in Three Trades
LFVN

LifeVantage Corp director Dayton Judd purchased 33,197 shares across three transactions between February 26 and March 2, 2026, spending $152,422. The purchases, disclosed on a Form 4 filing with the SEC, leave Judd with 80,359 directly owned shares and 749,325 indirectly held through Sudbury Capital Fund, LP. The trades arrive amid a fiscal Q2 report that met EPS expectations but missed revenue estimates, and after an analyst trimmed the price target while keeping a Buy rating.

Key Points

  • Dayton Judd purchased 33,197 LifeVantage shares across three transactions between Feb. 26 and Mar. 2, 2026, totaling $152,422.
  • After the trades Judd directly owns 80,359 shares and indirectly holds 749,325 shares through Sudbury Capital Fund, LP; the stock trades near a 52-week low and is down 73% year-over-year.
  • LifeVantage posted fiscal Q2 EPS of $0.15 (meeting expectations) but reported revenue of $48.9 million, below the anticipated $54.84 million; Lake Street cut its price target from $12.00 to $5.00 while keeping a Buy rating.

Director Dayton Judd of LifeVantage Corp (NASDAQ:LFVN) disclosed three separate purchases of the company's common stock in a Form 4 filed with the Securities and Exchange Commission. The transactions took place between February 26, 2026, and March 2, 2026, and together amounted to $152,422 for 33,197 shares.

The individual buys were recorded as follows: on February 26 Judd acquired 4,600 shares at a reported price of $4.58 per share within a stated range of $4.56 to $4.60; on February 27 he purchased 18,097 shares at $4.63 per share within a stated range of $4.59 to $4.65; and on March 2 he bought 10,500 shares at $4.53 per share within a stated range of $4.51 to $4.56.

Following these transactions, the filing shows Judd directly owns 80,359 LifeVantage shares. The filing also reports indirect holdings of 749,325 shares through Sudbury Capital Fund, LP.


Those insider purchases arrive while LifeVantage shares are trading close to their 52-week low of $3.90 and are down 73% over the past year. An InvestingPro assessment referenced in the disclosure indicates the stock may be undervalued on a Fair Value basis and notes a price-to-earnings ratio of 7.52 for the company.

The stock activity coincides with LifeVantage's recently reported second quarter of fiscal 2026 results. The company delivered earnings per share of $0.15, matching expectations, while revenue of $48.9 million missed the consensus forecast of $54.84 million. In response to the quarter, Lake Street Capital Markets reduced its price target on LifeVantage from $12.00 to $5.00, though the firm maintained a Buy rating. Lake Street cited the weaker-than-expected quarterly results and updated guidance as reasons for the cut.

Analysts highlighted that LifeVantage faced difficult year-over-year comparisons, specifically referencing the impact of last year’s MindBody GLP-1 product launch on the company’s revenue base. Those comparisons were noted as a meaningful headwind in the most recent reporting period.

The combination of insider buying, valuation commentary, a revenue shortfall, and a sharply reduced price target outlines the current set of signals available to investors. The Form 4 disclosure provides a precise record of Judd’s purchases in both share counts and per-share prices, while the earnings release and subsequent analyst action illustrate the operational and market challenges the company is navigating.

Risks

  • Revenue shortfall relative to analyst expectations - impacts the consumer products and financial markets sectors.
  • Challenging year-over-year comparisons due to last year’s MindBody GLP-1 product launch - impacts revenue recovery and visibility in the consumer wellness segment.
  • Market sentiment and analyst valuation shifts, evidenced by a lowered price target despite a Buy rating - affects investor perception and stock price volatility.

More from Insider Trading

UTI CEO Sells $2.1 Million in Shares as Stock Trades Near 52-Week High Mar 2, 2026 M&T Bank Senior Executive Disposes $1.84 Million in Shares; Exercises Options Worth $702,438 Mar 2, 2026 Fluor CFO Sells $1.5M in Stock Following Option Exercise Mar 2, 2026 IDEAYA Director Jeffrey Stein Acquires $1.65M Stake; Company Advances Oncology Program Mar 2, 2026 Interactive Communications Disposes of 17,610 Giftify Shares, Retains Majority Stake Mar 2, 2026